Pamidronate disodium and Doxorubicin hydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pamidronate disodium (pamidronate disodium) and Doxorubicin hydrochloride (doxorubicin hydrochloride). Common drug interactions include breast cancer among females and cardiac arrest among males.

The phase IV clinical study analyzes what interactions people have when they take Pamidronate disodium and Doxorubicin hydrochloride. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Pamidronate disodium?

Pamidronate disodium has active ingredients of pamidronate disodium. eHealthMe is studying from 5,200 Pamidronate disodium users. Check the latest studies of Pamidronate disodium.

What is Doxorubicin hydrochloride?

Doxorubicin hydrochloride has active ingredients of doxorubicin hydrochloride. eHealthMe is studying from 25,343 Doxorubicin hydrochloride users. Check the latest studies of Doxorubicin hydrochloride.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

20 people who take Pamidronate disodium and Doxorubicin hydrochloride together, and have interactions are studied.

Pamidronate disodium and Doxorubicin hydrochloride drug interactions.

What are the common drug interactions of Pamidronate Disodium and Doxorubicin Hydrochloride, by gender? *:

female:

  1. Breast cancer
  2. Neoplasm progression (growth of tumour)
  3. Second primary malignancy (after getting cure a cancer, a new cancer development)
  4. Depression
  5. Difficulty in walking
  6. Faecal incontinence (a lack of control over passing stool)
  7. Fall
  8. Fatigue (feeling of tiredness)
  9. Malignant neoplasm progression (cancer tumour came back)
  10. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

male:

  1. Cardiac arrest
  2. Discomfort
  3. Pain in extremity
  4. Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
  5. Skin fibrosis (fibrous tissue formation on skin)
  6. Skin induration (an abnormally hard spot or area on the skin)
  7. Skin tightness
  8. Subcutaneous nodule
  9. Xerosis (abnormal dryness of the skin or mucus membranes)
  10. Endocardial fibrosis (cardiac fibrosis refers to an abnormal thickening of the heart valves)

What are the common drug interactions of Pamidronate Disodium and Doxorubicin Hydrochloride, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Cardiac arrest
  2. Discomfort
  3. Endocardial fibrosis (cardiac fibrosis refers to an abnormal thickening of the heart valves)
  4. Extremity contracture (permanent shortening of a muscle or joint of arms and legs)
  5. Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
  6. Joint contracture (a permanent shortening of a muscle or joint)
  7. Metaplasia (change in the type of adult cells in a tissue to a form abnormal for that tissue)
  8. Mobility decreased (ability to move is reduced)
  9. Myocardial fibrosis (a condition in which the heart's muscle cells are impaired)
  10. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)

20-29:

n/a

30-39:

  1. Aspergilloma (fungus ball, is a clump of fungus which exists in a body cavity such as the lung)
  2. Asthenia (weakness)
  3. Bone marrow failure
  4. Constipation
  5. Mitral valve incompetence (inefficient heart valve)
  6. Mucosal inflammation (infection of mucous membrane)
  7. Multiple myeloma (cancer of the plasma cells)
  8. Mycobacterium tuberculosis complex test positive
  9. Nausea (feeling of having an urge to vomit)
  10. Night sweats (sweating in night)

40-49:

  1. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  2. Dysphagia (a condition in which swallowing is difficult or painful)
  3. Gamma-glutamyltransferase increased
  4. Hypokalaemia (low potassium)
  5. Laryngitis (inflammation of the larynx)
  6. Leukopenia (less number of white blood cells in blood)
  7. Neutropenia (an abnormally low number of neutrophils)
  8. Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
  9. Sinusitis (inflammation of sinus)
  10. Stomatitis (inflammation of mucous membrane of mouth)

50-59:

n/a

60+:

  1. Depression
  2. Difficulty in walking
  3. Decreased activity
  4. Diabetes mellitus inadequate control
  5. Disease progression
  6. Haemoglobin decreased
  7. Keratitis (eye's cornea, the front part of the eye, becomes inflamed)
  8. Myopathy (a muscular disease in which the muscle fibres do not function)
  9. Osteolysis (dissolution of bone)
  10. Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 3 people, 15.00%
  2. Breast Cancer: 2 people, 10.00%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.00%
  4. Renal Osteodystrophy (a bone disease occurs when the kidneys fail to maintain the proper levels of calcium and phosphorus in the blood): 1 person, 5.00%
  5. Nuclear Magnetic Resonance Imaging Brain: 1 person, 5.00%
  6. Metastases To Bone (cancer spreads to bone): 1 person, 5.00%
  7. Medical Device Complication: 1 person, 5.00%
  8. Joint Pain: 1 person, 5.00%
  9. Hypercalcaemia (elevated calcium (ca+) level in the blood): 1 person, 5.00%
  10. Headache (pain in head): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Pamidronate disodium and Doxorubicin hydrochloride?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pamidronate disodium and Doxorubicin hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pamidronate disodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Doxorubicin hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pamidronate disodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Doxorubicin hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on pamidronate disodium and doxorubicin hydrochloride (the active ingredients of Pamidronate disodium and Doxorubicin hydrochloride, respectively), and Pamidronate disodium and Doxorubicin hydrochloride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: